They never sold this qoute is from 2007 "The company also owns a significant stake (17%) in Genmab A/S, listed on the Nordic Exchange, which is valued at just under $450 million, and relates to three Phase III programs in Lymphomas and Head and Neck cancer. Data from a number of these programs is expected in 2007. It also owns 19% of IDM Pharma (IDMI) and has a 60% stake in a private company, Celldex. "
heres the link..... The company also owns a significant stake (17%) in Genmab A/S, listed on the Nordic Exchange, which is valued at just under $450 million, and relates to three Phase III programs in Lymphomas and Head and Neck cancer. Data from a number of these programs is expected in 2007. It also owns 19% of IDM Pharma (IDMI) and has a 60% stake in a private company, Celldex.
GLTY
D
Market Data 
Markets 
AI
